Also trades as: 0HF3.L (LSE) · $vol 0M
COR NYSE
Cencora, Inc.
1W: -5.2%
1M: +7.1%
3M: +2.1%
YTD: -3.8%
1Y: -2.0%
3Y: +75.7%
5Y: +178.3%
$325.37
-4.63 (-1.40%)
Weekly Expected Move ±3.1%
$310
$321
$331
$341
$352
Credit Risk of going bust: lower than 73% of companies Debt: 15.9% of company value Bonds: $362.8M held by 313 funds, 60 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $4.32 (down 99%), Cencora, Inc. would be worth roughly what it owes.
Total debt $11.72B against a stock market value of $62.09B.
Distance to default 8.20 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $6.00B (short-term plus half of long-term), stock volatility 32.3%; Altman Z'' 0.42. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $4.32 (down 99%), Cencora, Inc. would be worth roughly what it owes.
Total debt $11.72B against a stock market value of $62.09B.
Distance to default 8.20 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $6.00B (short-term plus half of long-term), stock volatility 32.3%; Altman Z'' 0.42. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
37 relationships37
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2021-04-01
Earliest Filing
2026-01-16
Latest Filing
partner: 14
customer: 8
investor: 8
target: 4
supplier: 2
acquirer: 1
Counterparties (Filed by COR)
37 relationshipsCompanies named in COR's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Citigroup Global Markets Inc. | — | partner | Lead financial advisor for the acquisition | 2026-01-16 | View |
| AmerisourceBergen Drug Corporation | — | customer | Servicer and originator of accounts receivable | 2025-07-03 | View |
| Walgreens Boots Alliance Holdings LLC | — | customer | Selling stockholder in share repurchase agreement | 2025-02-10 | View |
| Webster Equity Partners | — | target | Seller of Retina Midco, Inc. to Cencora, Inc. | 2025-01-02 | View |
| Retina Midco, Inc. | — | target | Target company acquired by Cencora, Inc. for $4.4 billion | 2025-01-02 | View |
| Walgreens Boots Alliance, Inc. | WBA | partner | Strategic partner with pharmaceutical distribution and global generic purchasing services agreements | 2024-12-10 | View |
| Retina Consultants of America | — | target | Target of proposed acquisition triggering potential note redemption | 2024-12-10 | View |
| Alliance Healthcare | — | partner | Acquired business entity | 2024-12-10 | View |
| Pharmalex | — | partner | Acquired business entity | 2024-12-10 | View |
| OneOncology | — | investor | Entity in which the Company made an investment | 2024-12-10 | View |
| Retina Consultants of America | — | target | Target of proposed acquisition by Cencora, Inc. | 2024-11-27 | View |
| AmerisourceBergen Drug Corporation | — | customer | Servicer and originator of accounts receivables in the securitization facility | 2024-10-15 | View |
| Walgreens Boots Alliance, Inc. | WBA | partner | Amendment to Shareholders Agreement regarding Board size and director nominations | 2024-08-16 | View |
| Walgreens Boots Alliance Holdings LLC | — | supplier | Selling stockholder in share repurchase agreement | 2024-08-05 | View |
| Walgreens Boots Alliance Holdings LLC | — | customer | Selling stockholder in share repurchase agreement | 2024-05-24 | View |
| Walgreens Boots Alliance Holdings LLC | — | customer | Selling stockholder in share repurchase agreement | 2024-02-09 | View |
| Walgreens Boots Alliance Holdings LLC | — | customer | Selling stockholder in a share repurchase agreement | 2023-11-14 | View |
| Walgreens Boots Alliance Holdings LLC | — | supplier | Selling stockholder in share repurchase agreement | 2023-06-20 | View |
| Walgreens Boots Alliance Holdings LLC | — | customer | Selling stockholder in share repurchase agreement | 2023-05-15 | View |
| Walgreens Boots Alliance Holdings LLC | — | customer | Selling stockholder in share repurchase agreement | 2022-12-12 | View |
| McKesson Corporation | MCK | partner | Settling Distributor in opioid-related lawsuit settlement | 2022-05-03 | View |
| Cardinal Health, Inc. | CAH | partner | Settling Distributor in opioid-related lawsuit settlement | 2022-05-03 | View |
| AmerisourceBergen Drug Corporation | — | partner | Servicer and originator under the receivables securitization facility. | 2021-11-08 | View |
| ASD Specialty Healthcare, LLC | — | partner | Originator under the receivables securitization facility. | 2021-11-08 | View |
| Amerisource Receivables Financial Corporation | — | partner | Seller and special purpose entity under the receivables securitization facility. | 2021-11-08 | View |
| Walgreen Co. | — | investor | Historical investor in the Framework Agreement | 2021-06-02 | View |
| AmerisourceBergen Corporation | — | acquirer | Company acquiring business from WBA in exchange for cash and stock | 2021-06-02 | View |
| Walgreens Boots Alliance, Inc. | — | investor | Investor holding shares and designating board members | 2021-06-02 | View |
| Walgreens Pharmacy Strategies, LLC | — | investor | Subsidiary of Walgreen Co. involved in prior agreements | 2021-06-02 | View |
| Walgreens Boots Alliance Development GmbH | — | investor | Affiliate of WBA mentioned in conflict of interest provisions | 2021-06-02 | View |
| WAB Holdings, LLC | WNC | investor | LLC jointly owned by Walgreens and Alliance Boots | 2021-06-02 | View |
| Alliance Boots Luxembourg S.à r.l. | — | investor | Subsidiary of Alliance Boots involved in prior agreements | 2021-06-02 | View |
| Alliance Boots GmbH | — | investor | Historical investor in the Framework Agreement | 2021-06-02 | View |
| AmerisourceBergen Drug Corporation | — | partner | Originator and servicer in receivables sale and purchase agreements | 2021-05-14 | View |
| ASD Specialty Healthcare, LLC | — | partner | Originator in receivables sale agreement | 2021-05-14 | View |
| Amerisource Receivables Financial Corporation | — | partner | Buyer and seller in receivables sale and purchase agreements | 2021-05-14 | View |
| Morgan, Lewis & Bockius LLP | — | partner | Legal counsel providing opinion on the validity of the Notes | 2021-04-01 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-21 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-09-25 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-08-14 | Officer/Director Change | View | |
| 2026-08-12 | Regulation FD | View | |
| 2026-08-05 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-08-05 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-06-15 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-29 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-06 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-23 | Regulation FD; Exhibits | View | |
| 2026-03-17 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2026-03-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-02-18 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-13 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Regulation FD Dis | Agreement | View |
| 2026-02-11 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-10 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-04 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-22 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2026-01-16 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-12-15 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR